The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23andMe Holding Co. COM CL A 90138Q108 6,342 700,000 SH   SOLE   700,000 0 0
Aclaris Therapeutics, Inc. COM 00461U105 22,648 1,258,243 SH   SOLE   1,258,243 0 0
Adagio Therapeutics, Inc. COM 00534A102 54,094 1,280,640 SH   SOLE   1,280,640 0 0
Cue Health Inc. COM 229790100 13,792 1,167,782 SH   SOLE   1,167,782 0 0
Cullinan Oncology, Inc. COM 230031106 61,648 2,731,410 SH   SOLE   2,731,410 0 0
FS Development Corp. II COM CL A 30318F100 5,995 602,500 SH   SOLE   602,500 0 0
Gemini Therapeutics, Inc. COM 36870G105 9,838 2,435,125 SH   SOLE   2,435,125 0 0
Helix Acquisition Corp. COM CL A G4444C102 2,488 250,000 SH   SOLE   250,000 0 0
Hims & Hers Health, Inc. COM CL A 433000106 7,969 1,056,922 SH   SOLE   1,056,922 0 0
Kinnate Biopharma Inc. COM 49705R105 20,143 875,001 SH   SOLE   875,001 0 0
Lucira Health, Inc. COM 54948U105 760 485,000 SH   SOLE   485,000 0 0
Nurix Therapeutics, Inc. COM 67080M103 13,528 451,522 SH   SOLE   451,522 0 0
Pharvaris N.V. COM N69605108 6,456 364,142 SH   SOLE   364,142 0 0
Population Health Investment Co., Inc. UNIT G71716123 5,603 960,000 SH   SOLE   960,000 0 0
Quantum-Si Incorporated COM CL A 74765K105 19,533 2,342,061 SH   SOLE   2,342,061 0 0
Research Alliance Corp. II COM CL A 760873109 4,925 500,000 SH   SOLE   500,000 0 0
Somalogic, Inc. COM CL A 83444K105 65,995 5,326,472 SH   SOLE   5,326,472 0 0